In this issue:
NHL, leukaemia and myeloma in type 2 diabetes
LEUKAEMIA SECTION
Prognostic relevance of integrated genetic profiling in AML
Allogeneic HSCT in AML with monosomal karyotype vs. other cytogenetics
Bosutinib chronic-phase CML after other TKI failure
Intensive vs. standard consolidation/maintenance in AML
LYMPHOMA SECTION
Initial therapy outcomes in mantle-cell lymphoma
Ofatumumab with CHOP in previously untreated FL
Ofatumumab monotherapy in rituximab-refractory FL
Monocyte count and OS in newly diagnosed FL
Reduced-intensity chemotherapy in advanced stage HL
Please login below to download this issue (PDF)